Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Digestive system drugs >  Emetics and antiemetics >  APOMORPHINE HYDROCHLORIDE

APOMORPHINE HYDROCHLORIDE

Basic information Safety Supplier Related

APOMORPHINE HYDROCHLORIDE Basic information

Product Name:
APOMORPHINE HYDROCHLORIDE
Synonyms:
  • (-)-apomorphiniumhydrochloride
  • (r)-id
  • (theta)-id
  • (-)-APO H CL
  • 4H-Dibenzode,gquinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)-
  • Apomorphine hydrochoride
  • g)quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo(dhydr
  • R()-Apomorphine hydrochloride,R(–)-10,11-Dihydroxyaporphine, R(–)-APO
CAS:
314-19-2
MF:
C17H18ClNO2
MW:
303.78
EINECS:
206-243-0
Mol File:
314-19-2.mol
More
Less

APOMORPHINE HYDROCHLORIDE Chemical Properties

Melting point:
>250℃
storage temp. 
Store at RT
solubility 
≥1.08 mg/mL in EtOH with ultrasonic; ≥12.9 mg/mL in DMSO; ≥5.12 mg/mL in H2O
form 
solid
EPA Substance Registry System
Apomorphine hydrochloride (314-19-2)
More
Less

Safety Information

RIDADR 
3249
HazardClass 
6.1(b)
PackingGroup 
III
Toxicity
mmo-sat 20 mg/plate MUREAV 137,17,84
More
Less

APOMORPHINE HYDROCHLORIDE Usage And Synthesis

Originator

Apomorphine hydrochloride,Nastech Pharmaceuticals Company, Inc.

Uses

Emetic.

Uses

(R)-(-)-Apomorphine Hydrochloride is a prototypical dopamine agonist. Potential treatment for Parkinson’s disease.

Manufacturing Process

2 Methods of producing of apomorphine
1. The apomorphine was obtained by dehydratation of morphine at heating to 120°C in the presence phosphoric acid and rendering of HCl gas over reaction mixture.
2. The morphine was converted to β-chloromorphine and then to dichlorodihydrodesoxymorphine at heating to 140°-150°C in the presence hydrochloric acid. Then apomorphine is obtained by dehydratation of dichlorodihydrodesoxymorphine.

brand name

Apokyn (Vernalis).

Therapeutic Function

Emetic, Expectorant, Hypnotic, Antiparkinsonian, Dopamine agonist

General Description

Apomorphine hydrochloride,(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolone-10,11-diol hydrochloride (Apokyn), is awhite or off-white powder or crystal soluble in hot water(pKa=8.92). Apormorphine is an aporphine alkaloid of thebenzoquinoline class. Oral apomorphine is poorly absorbedand has a bioavailability of less than 4%. Upon subcutaneousadministration, apomorphine is completely absorbed. Within10 to 20 minutes, the maximum concentration of the drug isdistributed from the blood plasma to the CSF. Other potentialroutes of administration include continuous subcutaneous infusion,intravenous infusion, intranasal spray application,sublingual, and rectal administration.23 The agent is highlylipophilic in nature, allowing for rapid diffusion across theBBB after injection. Apomorphine has a short plasma halflife;however, clinical effects may last from 60 to 90 minutes.Apomorphine displays a significant degree of interpatientvariability in its pharmacokinetic profile. Studies of bothintravenous and subcutaneous injection routes found this variation was not attributable to body weight, age, gender,and duration of PD or L-DOPA dose/duration alone.Apomorphine is extensively metabolized. Hypothesizedroutes include sulfation, N-demethylation, glucuronidation,and oxidation. Subcutaneous injections of apomorphine arerenally and hepatically cleared, with the majority appearingto be renally cleared. Dosage adjustments are needed in bothliver and renal impairment. The activity of apomorphine isbelieved to be caused by stimulation of postsynaptic D1- andD2-type receptors within the caudate/putamen in the brain.Apomorphine is indicated for the acute, intermittent treatmentof hypomobility, “off” episodes (“end-of-dose wearingoff” and unpredictable on/off episodes) associated with advancedPD.

Biological Activity

Prototypical dopamine agonist (pK i values are 6.43, 7.08, 7.59, 8.36 and 7.83 for human recombinant D 1 , D 2L , D 3 , D 4 and D 5 receptors respectively). Produces biphasic effects on locomotor activity, and displays anti-Parkinsonian and neuroprotective actions following systemic administration in vivo .

Clinical Use

Treatment of refractory motor fluctuations in Parkinson’s disease

Safety Profile

Poison by intravenous andintraperitoneal routes. Mutation data reported. When heated to decomposition itemits very toxic fumes of NOx and HCl.

Veterinary Drugs and Treatments

Apomorphine is used primarily as an emetic in dogs, and is considered the emetic of choice for dogs by many clinicians. It is sometimes used in cats, but its use in this species is somewhat controversial.

Drug interactions

Potentially hazardous interactions with other drugs
Antihypertensives: enhanced hypotensive effect.
Domperidone: possible increased risk of ventricular arrhythmias.
5HT3 -receptor antagonists: possibly increased hypotensive effects with ondansetron.
Nitrates: enhanced hypotensive effect.

Metabolism

After subcutaneous injection its fate can be described by a two-compartment model, with a distribution half-life of 5 (±1.1) minutes and an elimination half-life of 33 (±3.9) minutes. Clinical response correlates well with levels of apomorphine in the cerebrospinal fluid. Apomorphine is extensively metabolised in the liver, mainly by conjugation with glucuronic acid or sulfate; the major metabolite is apomorphine sulfate. It is also demethylated to produce norapomorphine. Most of a dose is excreted in urine, mainly as metabolites.

storage

Store at RT

APOMORPHINE HYDROCHLORIDESupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
EMMX Biotechnology LLC
Tel
888-539-0666
Email
info@emmx.com
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973186 4009686088
Email
3193328036@qq.com
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 +86-13028896684;
Email
sales@rrkchem.com
Shenzhen Botel Biotechnology Co. Ltd.
Tel
0755-22202135 13316968096
Email
1979313431@qq.com